3,4-dihydroxyphenylacetic acid has been researched along with Hemorrhage, Subarachnoid in 7 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Parkinson's disease have a decrement in homovanillic acid that is reversed by treatment with L-3,4-dihydroxyphenylalanine." | 1.27 | Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method. ( Aguado, EG; de Yebenes, JG; Mena, MA, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moussouttas, M | 2 |
| Lai, EW | 2 |
| Dombrowski, K | 2 |
| Huynh, TT | 2 |
| Khoury, J | 2 |
| Carmona, G | 1 |
| DeCaro, M | 1 |
| Pacak, K | 2 |
| Lambert, G | 1 |
| Naredi, S | 1 |
| Edén, E | 1 |
| Rydenhag, B | 1 |
| Friberg, P | 1 |
| Mena, MA | 1 |
| Aguado, EG | 1 |
| de Yebenes, JG | 1 |
| Hirata, K | 2 |
| Kawano, T | 1 |
| Mori, K | 1 |
| Minegishi, A | 1 |
| Ishizaki, T | 1 |
| Yoshida, Y | 1 |
| Ahagon, A | 1 |
| Shibata, N | 1 |
| Kobayashi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Myocardial Dysfunction at Early Phase of Traumatic Brain Injury : Evaluation by Two Dimensional and Speckle Tracking Transthoracic Echocardiography[NCT02380482] | 40 participants (Actual) | Interventional | 2014-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for 3,4-dihydroxyphenylacetic acid and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cardiomyopathies; Catecholamines; Dihydroxyphenylalanine; Dopa | 2011 |
Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Critical Illness; Dihydroxyphenylala | 2012 |
Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Biogenic Monoamines; Craniocerebral Trauma; Dihydroxyph | 2002 |
Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Depression; | 1984 |
Changes in monoaminergic neuronal function in the lower brain stem following subarachnoid hemorrhage induced in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Stem; Chromatography, High Pressure Liquid; Electroch | 1993 |
[Changes in monoamine metabolites measured by in vivo microdialysis of the brainstem following experimental subarachnoid hemorrhage in rats].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Stem; Chromatography, High Press | 1992 |
Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Catecholamines; Cerebrovascular Disorders; Dopamine; Ep | 1987 |